Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
11.11
-0.04 (-0.36%)
May 5, 2026, 12:20 PM EDT - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.75 billion as of May 5, 2026. Its market cap has decreased by -30.97% in one year.
Market Cap
3.75B
Enterprise Value
4.10B
1-Year Change
-30.97%
Ranking
Category
Stock Price
$11.11
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.75B, an increase of 3,155.47%. That is a compound annual growth rate of 50.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 3.79B | 49.94% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 4.32B |
| Travere Therapeutics | 4.15B |
| Oruka Therapeutics | 3.98B |
| Veradermics | 3.93B |
| ACADIA Pharmaceuticals | 3.80B |
| Viking Therapeutics | 3.69B |
| Catalyst Pharmaceuticals | 3.53B |
| NewAmsterdam Pharma Company | 3.43B |